Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans - towards treatment with probiotics

Beneficial Microbes

Volumn 7, Issue 1, 2016, Pages 11-22

  Stenman, L K ^a   Burcelin, R ^b   Lahtinen, S ^a  

^a DUPONT COMPANY   (United States)

^b CHU RANGUEIL   (France)

Author keywords

Barrier function; Bifidobacterium; Diet; Obesity; Probiotics

Indexed keywords

GLUCOSE; PROBIOTIC AGENT;

ANIMAL; HUMAN; INTESTINE FLORA; METABOLIC DISORDER; METABOLISM; MICROBIOLOGY; WEIGHT GAIN;

ANIMALS; GASTROINTESTINAL MICROBIOME; GLUCOSE; HUMANS; METABOLIC DISEASES; PROBIOTICS; WEIGHT GAIN;

EID: 84958162059     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2015.0069     Document Type: Review

References (93)

1. Ajslev, T.A., Andersen, C.S., Gamborg, M., Sorensen, T.I. and Jess, T., 2011. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. International Journal of Obesity 35: 522-529.
2. Amar, J., Burcelin, R., Ruidavets, J.B., Cani, P.D., Fauvel, J., Alessi, M.C., Chamontin, B. and Ferrieres, J., 2008. Energy intake is associated with endotoxemia in apparently healthy men. American Journal of Clinical Nutrition 87: 1219-1223.
3. Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermudez-Humaran, L.G., Smirnova, N., Berge, M., Sulpice, T., Lahtinen, S., Ouwehand, A., Langella, P., Rautonen, N., Sansonetti, P.J. and Burcelin, R., 2011. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 3: 559-572.
4. Andreasen, A.S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R.M., Moller, K., Svendsen, K.D., Jakobsen, M. and Pedersen, B.K., 2010. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. British Journal of Nutrition 104: 1831-1838.
5. Armougom, F., Henry, M., Vialettes, B., Raccah, D. and Raoult, D., 2009. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PloS One 4: e7125.
6. Arora, T., Singh, S. and Sharma, R.K., 2013. Probiotics: interaction with gut microbiome and antiobesity potential. Nutrition 29: 591-596.
7. Asemi, Z., Samimi, M., Tabassi, Z., Naghibi Rad, M., Rahimi Foroushani, A., Khorammian, H. and Esmaillzadeh, A., 2013. Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial. European Journal of Clinical Nutrition 67: 71-74.
8. Azad, M.B., Bridgman, S.L., Becker, A.B. and Kozyrskyj, A.L., 2014. Infant antibiotic exposure and the development of childhood overweight and central adiposity. International Journal of Obesity 38: 1290-1298.
9. Bailey, L.C., Forrest, C.B., Zhang, P., Richards, T.M., Livshits, A. and DeRusso, P.A., 2014. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatrics 168: 1063-1069.
10. Bindels, L.B., Delzenne, N.M., Cani, P.D. and Walter, J., 2015. Towards a more comprehensive concept for prebiotics. Nature Reviews Gastroenterology and Hepatology 12: 303-310.
11. Bruce, K.D. and Byrne, C.D., 2009. The metabolic syndrome: common origins of a multifactorial disorder. Postgraduate Medical Journal 85: 614-621.
12. Brun, P., Castagliuolo, I., Di Leo, V., Buda, A., Pinzani, M., Palu, G. and Martines, D., 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. American Journal of Physiology - Gastrointestinal and Liver Physiology 292: G518-G525.
13. Burcelin, R., 2012. Regulation of metabolism: a cross talk between gut microbiota and its human host. Physiology 27: 300-307.
14. Burcelin, R., Garidou, L. and Pomie, C., 2012. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. Seminars in Immunology 24: 67-74.
15. Caesar, R., Reigstad, C.S., Backhed, H.K., Reinhardt, C., Ketonen, M., Lunden, G.O., Cani, P.D. and Backhed, F., 2012. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 61: 1701-1707.
16. Cani, P.D. and Delzenne, N.M., 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design 15: 1546-1558.
17. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C. and Burcelin, R., 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
18. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
19. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D.M., Muccioli, G.G. and Delzenne, N.M., 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
20. Carlsson, A.H., Yakymenko, O., Olivier, I., Hakansson, F., Postma, E., Keita, A.V. and Soderholm, J.D., 2013. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scandinavian Journal of Gastroenterology 48: 1136-1144.
21. Clarke, S.F., Murphy, E.F., O'Sullivan, O., Lucey, A.J., Humphreys, M., Hogan, A., Hayes, P., O'Reilly, M., Jeffery, I.B., Wood-Martin, R., Kerins, D.M., Quigley, E., Ross, R.P., O'Toole, P.W., Molloy, M.G., Falvey, E., Shanahan, F. and Cotter, P.D., 2014. Exercise and associated dietary extremes impact on gut microbial diversity. Gut 63: 1913-1920.
22. Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Quinquis, B., Levenez, F., Galleron, N., Gougis, S., Rizkalla, S., Batto, J.M., Renault, P., ANR MicroObes consortium, Dore, J., Zucker, J.D., Clement, K. and Ehrlich, S.D., 2013. Dietary intervention impact on gut microbial gene richness. Nature 500: 585-588.
23. Dao, M.C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O., Kayser, B.D., Levenez, F., Chilloux, J., Hoyles, L., Consortium, M.I.-O., Dumas, M.E., Rizkalla, S.W., Dore, J., Cani, P.D. and Clement, K., in press. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. DOI: 10.1136/gutjnl-2014-308778.
24. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., Biddinger, S.B., Dutton, R.J. and Turnbaugh, P.J., 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559-563.
25. Denou, E., Lolmede, K., Garidou, L., Pomie, C., Chabo, C., Lau, T.C., Fullerton, M.D., Nigro, G., Zakaroff-Girard, A., Luche, E., Garret, C., Serino, M., Amar, J., Courtney, M., Cavallari, J.F., Henriksbo, B.D., Barra, N.G., Foley, K.P., McPhee, J.B., Duggan, B.M., O'Neill, H.M., Lee, A.J., Sansonetti, P., Ashkar, A.A., Khan, W.I., Surette, M.G., Bouloumie, A., Steinberg, G.R., Burcelin, R. and Schertzer, J.D., 2015. Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance. EMBO Molecular Medicine 7: 259-274.
26. Diabetes Prevention Program Research Group, Knowler, W.C., Fowler, S.E., Hamman, R.F., Christophi, C.A., Hoffman, H.J., Brenneman, A.T., Brown-Friday, J.O., Goldberg, R., Venditti, E. and Nathan, D.M., 2009. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet 374: 1677-1686.
27. DiRienzo, D.B., 2014. Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets. Nutrition Reviews 72: 18-29.
28. Duncan, S.H., Lobley, G.E., Holtrop, G., Ince, J., Johnstone, A.M., Louis, P. and Flint, H.J., 2008. Human colonic microbiota associated with diet, obesity and weight loss. International Journal of Obesity 32: 1720-1724.
29. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J. and Paquot, N., 2014. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice 105: 141-150.
30. Ettinger, G., MacDonald, K., Reid, G. and Burton, J.P., 2014. The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes 5: 719-728.
31. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., de Vos, W.M. and Cani, P.D., 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the USA 110: 9066-9071.
32. Everard, A., Matamoros, S., Geurts, L., Delzenne, N.M. and Cani, P.D., 2014. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice. MBio 5: e01011-01014.
33. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: http://tinyurl.com/ou88oa2.
34. Fei, N. and Zhao, L., 2013. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME Journal 7: 880-884.
35. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N. and Pace, N.R., 2007. Molecular-phylogenetic characterisation of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the USA 104: 13780-13785.
36. Garidou, L., Pomie, C., Klopp, P., Waget, A., Charpentier, J., Aloulou, M., Giry, A., Serino, M., Stenman, L., Lahtinen, S., Dray, C., Iacovoni, J.S., Courtney, M., Collet, X., Amar, J., Servant, F., Lelouvier, B., Valet, P., Eberl, G., Fazilleau, N., Douin-Echinard, V., Heymes, C. and Burcelin, R., 2015. The gut microbiota regulates intestinal CD4 T cells expressing ROR-gamma-t and controls metabolic disease. Cell Metabolism 22: 100-112.
37. Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J.T., Spector, T.D., Clark, A.G. and Ley, R.E., 2014. Human genetics shape the gut microbiome. Cell 159: 789-799.
38. Guarner, V. and Rubio-Ruiz, M.E., 2015. Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. Interdisciplinary Topics in Gerontology 40: 99-106.
39. Hartstra, A.V., Bouter, K.E., Backhed, F. and Nieuwdorp, M., 2015. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 38: 159-165.
40. Hotamisligil, G.S., 2003. Inflammatory pathways and insulin action. International Journal of Obesity and Related Metabolic Disorders 27 Suppl. 3: S53-S55.
41. Hsieh, F.C., Lee, C.L., Chai, C.Y., Chen, W.T., Lu, Y.C. and Wu, C.S., 2013. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutrition and Metabolism 10: 35.
42. Ilmonen, J., Isolauri, E., Poussa, T. and Laitinen, K., 2011. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clinical Nutrition 30: 156-164.
43. Ivey, K.L., Hodgson, J.M., Kerr, D.A., Lewis, J.R., Thompson, P.L. and Prince, R.L., 2014. The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial. European Journal of Clinical Nutrition 68: 447-452.
44. Jumpertz, R., Le, D.S., Turnbaugh, P.J., Trinidad, C., Bogardus, C., Gordon, J.I. and Krakoff, J., 2011. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. American Journal of Clinical Nutrition 94: 58-65.
45. Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M. and Tsuchida, T., 2010. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 64: 636-643.
46. Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., Ikuyama, K., Kagoshima, M. and Tsuchida, T., 2013. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition 110: 1696-1703.
47. Kaiko, G.E. and Stappenbeck, T.S., 2014. Host-microbe interactions shaping the gastrointestinal environment. Trends in Immunology 35: 538-548.
48. Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A. and Kimura, I., 2015. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7: 2839-2849.
49. Korpela, K., Flint, H.J., Johnstone, A.M., Lappi, J., Poutanen, K., Dewulf, E., Delzenne, N., De Vos, W.M. and Salonen, A., 2014. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PloS One 9: e90702.
50. Laitinen, K., Poussa, T., Isolauri, E., Nutrition, A.M.I. and Intestinal Microbiota, G., 2009. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. British Journal of Nutrition 101: 1679-1687.
51. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., Grarup, N., Jorgensen, T., Brandslund, I., Nielsen, H.B., Juncker, A.S., Bertalan, M., Levenez, F., Pons, N., Rasmussen, S., Sunagawa, S., Tap, J., Tims, S., Zoetendal, E.G., Brunak, S., Clement, K., Dore, J., Kleerebezem, M., Kristiansen, K., Renault, P., Sicheritz-Ponten, T., De Vos, W.M., Zucker, J.D., Raes, J., Hansen, T., MetaHIT consortium, Bork, P., Wang, J., Ehrlich, S.D. and Pedersen, O., 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-546.
52. Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I., 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
53. Luche, E., Cousin, B., Garidou, L., Serino, M., Waget, A., Barreau, C., Andre, M., Valet, P., Courtney, M., Casteilla, L. and Burcelin, R., 2013. Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Molecular Metabolism 2: 281-291.
54. Million, M., Angelakis, E., Maraninchi, M., Henry, M., Giorgi, R., Valero, R., Vialettes, B. and Raoult, D., 2013. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. International Journal of Obesity 37: 1460-1466.
55. Million, M., Maraninchi, M., Henry, M., Armougom, F., Richet, H., Carrieri, P., Valero, R., Raccah, D., Vialettes, B. and Raoult, D., 2012. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. International Journal of Obesity 36: 817-825.
56. Mueller, N.T., Whyatt, R., Hoepner, L., Oberfield, S., Dominguez-Bello, M.G., Widen, E.M., Hassoun, A., Perera, F. and Rundle, A., 2015. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. International Journal of Obesity 39: 665-670.
57. Murphy, R., Stewart, A.W., Braithwaite, I., Beasley, R., Hancox, R.J., Mitchell, E.A. and the ISAAC Phase Three Study Group, 2014. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. International Journal of Obesity 38: 1115-1119.
58. Omar, J.M.C., Y.-M.; Jones, M.L., Prakash, S. and Jones, P.J.H., 2013. Lactobacillus fermentum and Lactobacillus amylovorus as probiotics alter body adiposity and gut microflora in healthy persons. Journal of Functional Foods 5: 116-123.
59. Patil, D.P., Dhotre, D.P., Chavan, S.G., Sultan, A., Jain, D.S., Lanjekar, V.B., Gangawani, J., Shah, P.S., Todkar, J.S., Shah, S., Ranade, D.R., Patole, M.S. and Shouche, Y.S., 2012. Molecular analysis of gut microbiota in obesity among Indian individuals. Journal of Biosciences 37: 647-657.
60. Rajilic-Stojanovic, M., Heilig, H.G., Tims, S., Zoetendal, E.G. and De Vos, W.M., 2013. Long-term monitoring of the human intestinal microbiota composition. Environmental Microbiology 15: 1146-1159.
61. Rajkumar, H., Mahmood, N., Kumar, M., Varikuti, S.R., Challa, H.R. and Myakala, S.P., 2014. Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial. Mediators of Inflammation 2014: 348959.
62. Razmpoosh, E., Javadi, M., Ejtahed, H.S. and Mirmiran, P., in press. Probiotics as beneficial agents on the management of diabetes mellitus: a systematic review. Diabetes/Metabolism Research and Reviews. doi: 10.1002/dmrr.2665
63. Remely, M., Hippe, B., Geretschlaeger, I., Stegmayer, S., Hoefinger, I. and Haslberger, A., 2015a. Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wiener Klinische Wochenschrift 127: 394-398.
64. Remely, M., Tesar, I., Hippe, B., Gnauer, S., Rust, P. and Haslberger, A.G., 2015b. Gut microbiota composition correlates with changes in body fat content due to weight loss. Beneficial Microbes 6: 431-439
65. Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., De Vos, W.M. and Satokari, R., 2015. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Applied and Environmental Microbiology 81: 3655-3662.
66. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., Muehlbauer, M.J., Ilkayeva, O., Semenkovich, C.F., Funai, K., Hayashi, D.K., Lyle, B.J., Martini, M.C., Ursell, L.K., Clemente, J.C., Van Treuren, W., Walters, W.A., Knight, R., Newgard, C.B., Heath, A.C. and Gordon, J.I., 2013. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214.
67. Saari, A., Virta, L.J., Sankilampi, U., Dunkel, L. and Saxen, H., 2015. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 135: 617-626.
68. Sajjad, A., Mottershead, M., Syn, W.K., Jones, R., Smith, S. and Nwokolo, C.U., 2005. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. Alimentary Pharmacology and Therapeutics 22: 291-299.
69. Salonen, A. and De Vos, W.M., 2014. Impact of diet on human intestinal microbiota and health. Annual Review of Food Science and Technology 5: 239-262.
70. Salonen, A., Lahti, L., Salojarvi, J., Holtrop, G., Korpela, K., Duncan, S.H., Date, P., Farquharson, F., Johnstone, A.M., Lobley, G.E., Louis, P., Flint, H.J. and De Vos, W.M., 2014. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME Journal 8: 2218-2230.
71. Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., Ngom-Bru, C., Berger, B., Philippe, L., Ammon-Zuffrey, C., Leone, P., Chevrier, G., St-Amand, E., Marette, A., Dore, J. and Tremblay, A., 2014. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition 111: 1507-1519.
72. Schertzer, J.D., Tamrakar, A.K., Magalhaes, J.G., Pereira, S., Bilan, P.J., Fullerton, M.D., Liu, Z., Steinberg, G.R., Giacca, A., Philpott, D.J. and Klip, A., 2011. NOD1 activators link innate immunity to insulin resistance. Diabetes 60: 2206-2215.
73. Schwiertz, A., Taras, D., Schafer, K., Beijer, S., Bos, N.A., Donus, C. and Hardt, P.D., 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195.
74. Sharafedtinov, K.K., Plotnikova, O.A., Alexeeva, R.I., Sentsova, T.B., Songisepp, E., Stsepetova, J., Smidt, I. and Mikelsaar, M., 2013. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients--a randomized double-blind placebo-controlled pilot study. Nutrition Journal 12: 138.
75. Shin, N.R., Lee, J.C., Lee, H.Y., Kim, M.S., Whon, T.W., Lee, M.S. and Bae, J.W., 2014. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63: 727-735.
76. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottiere, H.M., Dore, J., Marteau, P., Seksik, P. and Langella, P., 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences of the USA 105: 16731-16736.
77. Stenman, L.K., Holma, R., Eggert, A. and Korpela, R., 2013. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. American Journal of Physiology - Gastrointestinal and Liver Physiology 304: G227-G234.
78. Stenman, L.K., Holma, R. and Korpela, R., 2012. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World Journal of Gastroenterology 18: 923-929.
79. Stenman, L.K., Waget, A., Garret, C., Klopp, P., Burcelin, R. and Lahtinen, S., 2014. Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Beneficial Microbes 5: 437-445.
80. Thuny, F., Richet, H., Casalta, J.P., Angelakis, E., Habib, G. and Raoult, D., 2010. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PloS One 5: e9074.
81. Tims, S., Derom, C., Jonkers, D.M., Vlietinck, R., Saris, W.H., Kleerebezem, M., De Vos, W.M. and Zoetendal, E.G., 2013. Microbiota conservation and BMI signatures in adult monozygotic twins. ISME Journal 7: 707-717.
82. Trasande, L., Blustein, J., Liu, M., Corwin, E., Cox, L.M. and Blaser, M.J., 2013. Infant antibiotic exposures and early-life body mass. International Journal of Obesity 37: 16-23.
83. Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Uusitupa, M. and the Finnish Diabetes Prevention Study Group, 2001. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344: 1343-1350.
84. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., Egholm, M., Henrissat, B., Heath, A.C., Knight, R. and Gordon, J.I., 2009. A core gut microbiome in obese and lean twins. Nature 457: 480-484.
85. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
86. Verdam, F.J., Fuentes, S., De Jonge, C., Zoetendal, E.G., Erbil, R., Greve, J.W., Buurman, W.A., De Vos, W.M. and Rensen, S.S., 2013. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity 21: E607-E615.
87. Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., Sitaraman, S.V., Knight, R., Ley, R.E. and Gewirtz, A.T., 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328: 228-231.
88. Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., Dallinga-Thie, G.M., Ackermans, M.T., Serlie, M.J., Oozeer, R., Derrien, M., Druesne, A., Van Hylckama Vlieg, J.E., Bloks, V.W., Groen, A.K., Heilig, H.G., Zoetendal, E.G., Stroes, E.S., De Vos, W.M., Hoekstra, J.B. and Nieuwdorp, M., 2012. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143: 913-916 e917.
89. Walters, W.A., Xu, Z. and Knight, R., 2014. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Letters 588: 4223-4233.
90. Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., van-Hylckama Vlieg, J.E., Strissel, K., Zhao, L., Obin, M. and Shen, J., 2015. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME Journal 9: 1-15.
91. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante, A.W., Jr., 2003. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112: 1796-1808.
92. Winer, D.A., Winer, S., Shen, L., Wadia, P.P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M.G., Alonso, M.N., Leong, H.X., Glassford, A., Caimol, M., Kenkel, J.A., Tedder, T.F., McLaughlin, T., Miklos, D.B., Dosch, H.M. and Engleman, E.G., 2011. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nature Medicine 17: 610-617.
93. Wu, H., Ghosh, S., Perrard, X.D., Feng, L., Garcia, G.E., Perrard, J.L., Sweeney, J.F., Peterson, L.E., Chan, L., Smith, C.W. and Ballantyne, C.M., 2007. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115: 1029-1038.